Drug Discovery Solutions

  1. PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production 3/17/2023

    PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.

  2. Recombinant Antibody Production 6/5/2026

    Curia has extensive experience with constructing and producing antibodies in our mammalian platforms.

  3. Drug Metabolism And Pharmacokinetics (DMPK) 5/28/2026

    Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.

  4. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  5. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  6. Medicinal Chemistry 5/28/2026

    Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.

  7. Empowering The Future Of Medicine 2/23/2026

    Accelerate from development to commercialization with scalable manufacturing solutions. Integrated digital systems and expert technical advocacy ensure regulatory excellence and rapid batch release.

  8. LV Edge System 11/24/2025

    By transitioning from a 4-plasmid transient system to 1- or 0-plasmid configurations, the LV Edge systems reduce or eliminate the need for GMP plasmids, lowering costs and supply chain risks.

  9. Monoclonal Antibodies & Antibody-Drug Conjugates 2/18/2026

    A clear overview of analytical solutions for mAbs and ADCs, covering structural characterization, potency, genetic QC, stability, and biosafety. Learn how comprehensive testing supports safer, more consistent biologics from early development through commercial release.

  10. TARGATT™ CHO Cells: Rapid, Stable CHO Cell Generation For Bioproduction 9/30/2025

    With our proprietary TARGATT™ technology for site-specific integration of large DNA fragments, we’ve developed a series of TARGATT™ “master” cell lines, including engineered CHO.